Abstract | OBJECTIVE: STUDY DESIGN: A randomized noninferiority trial was performed in all Dutch perinatal centers. Women with symptoms of preterm labor between 24 and 34 weeks, intact membranes, cervical length between 10 and 30 mm, and negative fibronectin test were randomly allocated to nifedipine (80 mg/day) or placebo. The primary outcome was delivery within 7 days. Secondary outcomes were severe neonatal morbidity and mortality. We also followed all eligible nonrandomized women. RESULTS: We allocated 37 women to nifedipine and 36 women to placebo. In the nifedipine group, three women (8.1%) delivered within 7 days, compared with one woman (2.8%) in the placebo group (difference -5.3%; one-sided 95% confidence limit 4.5%). Median gestational age at delivery were respectively 37 + 0 (interquartile range [IQR] 34 + 6 to 38 + 5) and 38 + 2 (IQR 37 + 0 to 39 + 6) weeks (p = 0.008). In the nifedipine group, three pregnancies (8.1%) had a poor outcome; there were no poor outcomes in the placebo group. We observed similar trends in eligible nonrandomized women. CONCLUSION:
|
Authors | Jolande Y Vis, Gert-Jan van Baaren, Femke F Wilms, Martijn A Oudijk, Anneke Kwee, Martina M Porath, Hubertina C Scheepers, Marc E Spaanderman, Kitty W Bloemenkamp, Jan M van Lith, Antoinette C Bolte, Caroline J Bax, Jérôme Cornette, Johannes J Duvekot, Sebastiaan W Nij Bijvank, Jim van Eyck, Maureen T Franssen, Krystyna M Sollie, Mallory Woiski, Frank P Vandenbussche, Joris A van der Post, Patrick M Bossuyt, Brent C Opmeer, Ben W Mol |
Journal | American journal of perinatology
(Am J Perinatol)
Vol. 32
Issue 5
Pg. 451-60
(Apr 2015)
ISSN: 1098-8785 [Electronic] United States |
PMID | 25486290
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA. |
Chemical References |
- Fibronectins
- Tocolytic Agents
- Nifedipine
|
Topics |
- Adult
- Cervical Length Measurement
- Female
- Fibronectins
(analysis)
- Gestational Age
- Humans
- Netherlands
- Nifedipine
(therapeutic use)
- Obstetric Labor, Premature
(drug therapy, prevention & control)
- Pregnancy
- Pregnancy Complications
(drug therapy, prevention & control)
- Tocolytic Agents
(therapeutic use)
- Treatment Outcome
- Young Adult
|